- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03921931
Retinal Photoreceptor Outer Segment Length Before and After Light Stimulation - a Pilot Study
March 14, 2023 updated by: Doreen Schmidl, Medical University of Vienna
Assessment of Retinal Photoreceptor Outer Segment Length With Optical Coherence Tomography Before and After Light Stimulation - a Pilot Study
It has been shown that reactions of human retinal photoreceptors to a light stimulus can be measured with custom-made, research prototype optical coherence tomography (OCT) systems.
This can be used as a biomarker for the function of the photoreceptors.
Due to the high technical demands on the system, however, the technique is currently not available for clinical purposes.
In this pilot study a protocol to measure changes in retinal photoreceptor layer thickness before and after light stimulation shall be developed based on a commercial OCT system and newly developed algorithms.
Other variables, such as circadian processes shall be investigated as well.
After measurements in healthy volunteers, the protocol is planned to be applied in patients with primary open angle glaucoma (POAG) and age-related macular degeneration (AMD) to test for feasibility of the method in these patient groups.
Study Overview
Status
Recruiting
Intervention / Treatment
Study Type
Interventional
Enrollment (Anticipated)
35
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Doreen Schmidl, MD,PhD
- Phone Number: 29810 0043140400
- Email: doreen.schmidl@meduniwien.ac.at
Study Locations
-
-
-
Vienna, Austria, 1090
- Recruiting
- Medical University of Vienna, Department of Clinical Pharmacology
-
Contact:
- Doreen Schmidl, MD, PhD
- Phone Number: 29810 0043140400
- Email: doreen.schmidl@meduniwien.ac.at
-
Sub-Investigator:
- Alina Messner, MD
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
All
Description
Inclusion Criteria:
- men and women aged over 18 years
- signed informed consent form
- ametropia below 3 diopters
- ability and willingness to follow instructions
for healthy volunteers:
- normal ophthalmologic findings
for primary open angle glaucoma patients (POAG):
- diagnosed POAG
- MD <= 10 dB
for age-related macular degeneration (AMD):
- diagnosed dry AMD
- diagnosed stage II or stage III AMD
Exclusion Criteria:
- Presence of any abnormalities preventing reliable measurements
- Ocular inflammation and ocular disease interfering with the study aims
- Use of photosensitizing medication (phototoxic drugs, photoallergic drugs) in the 3 months preceding the study
- Presence of any condition with the possibility of causing photosensitivity, including systemic lupus erythematosus SLE, Porphyria, Vitiligo, Xeroderma Pigmentosum and Albinism
- Presence of any form of epilepsy
- Ocular surgery in the 3 months preceding the study
- Pregnancy, planned pregnancy or lactating
- Any medical or surgical history, disorder or disease such as acute or chronic severe organic disease
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Basic Science
- Allocation: Non-Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: healthy volunteers
light stimulation
|
Stimulation of the retina with white light
|
Experimental: primary open angle glaucoma patients
light stimulation
|
Stimulation of the retina with white light
|
Experimental: age-related macular degeneration patients
light stimulation
|
Stimulation of the retina with white light
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Light stimulation
Time Frame: 1 day
|
Optical path length changes between inner segment outer segment junction and retinal pigment epithelium (RPE) will be measured with OCT in 15 healthy volunteers, 10 POAG patients and 10 AMD patients before and after light stimulation
|
1 day
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Light stimulation of contralateral eye
Time Frame: 1 day
|
Optical path length changes between inner segment outer segment junction and retinal pigment epithelium (RPE) will be measured with OCT in 15 healthy volunteers, 10 POAG patients and 10 AMD patients before and after light stimulation in the contralateral eye
|
1 day
|
Difference in photoreceptor layer thickness over the course of 8 hours
Time Frame: 8 hours
|
Influence of circadian rhythm on the length of retinal photoreceptor outer segments
|
8 hours
|
En face maps
Time Frame: 1 day
|
test an algorithm for production of en face maps of retinal photoreceptor outer segment length
|
1 day
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Doreen Schmidl, MD,PhD, Department of Clinical Pharmacology, Medical University of Vienna
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
November 26, 2018
Primary Completion (Anticipated)
May 31, 2023
Study Completion (Anticipated)
May 31, 2023
Study Registration Dates
First Submitted
April 4, 2019
First Submitted That Met QC Criteria
April 17, 2019
First Posted (Actual)
April 19, 2019
Study Record Updates
Last Update Posted (Actual)
March 15, 2023
Last Update Submitted That Met QC Criteria
March 14, 2023
Last Verified
March 1, 2023
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- OPHT-050418
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Primary Open-angle Glaucoma
-
Omar SaidCompletedGlaucoma,Primary Open-Angle ,Primary Angle ClosureEgypt
-
Glaucot Teknoloji Anonim SirketiRecruitingPrimary Open-Angle GlaucomaTurkey
-
China Medical University HospitalCompletedEffect of Acupuncture on Visual Acuity and Visual Field in Patients With Primary Open-angle GlaucomaPrimary Open-angle GlaucomaTaiwan
-
InnFocus Inc.CompletedPrimary Open-angle GlaucomaSpain, United States, United Kingdom, France, Italy
-
Glaukos CorporationTerminatedPrimary Open-Angle GlaucomaUnited States
-
Rehab mahmoud abdelhamid mohamedCairo UniversityCompletedPrimary Open-angle GlaucomaEgypt
-
Cairo UniversityUniversity of LuebeckUnknown
-
Xiaodong ZhouCompletedPrimary Open-angle Glaucoma
-
Peking UniversityRecruitingPrimary Open Angle Glaucoma | Ocular Hypertension | Primary Open Angle Glaucoma of Both Eyes | Primary Open-Angle Glaucoma, Unspecified Eye | Suspect GlaucomaChina
-
Qlaris Bio, Inc.RecruitingPrimary Open Angle Glaucoma of Both Eyes | Primary Open Angle Glaucoma (POAG) | Primary Open-Angle Glaucoma, Unspecified Eye | Ocular Hypertension (OHT)United States
Clinical Trials on White light stimulation
-
University of North Carolina, Chapel HillNot yet recruitingChronic Pain | Chronic Low-back Pain | FibromyalgiaUnited States
-
University of WashingtonIcahn School of Medicine at Mount Sinai; University of North Texas Health Science...CompletedSleep | Traumatic Brain Injury | TBIUnited States
-
Icahn School of Medicine at Mount SinaiCompletedFatigue | Traumatic Brain InjuryUnited States
-
Chang Gung Memorial HospitalRecruitingDelirium | Circadian DysrhythmiaTaiwan
-
Matthew Neal MDTerminatedPancreatic Neoplasms | Rectal NeoplasmsUnited States
-
VA Office of Research and DevelopmentCompletedInsomnia | Aging | Falls | BalanceUnited States
-
Children's Hospital Medical Center, CincinnatiRecruiting
-
New York Institute of TechnologyRecruitingPain, Chronic | Ehlers-Danlos SyndromeUnited States
-
Eskisehir Osmangazi UniversityCompletedCancer-related Fatigue | Light; Therapy, ComplicationsTurkey
-
Changhai HospitalGuilin Medical University, China; Shanxi Province Cancer Hospital; First People... and other collaboratorsUnknownEarly Gastric CancerChina